WASHINGTON: As drug companies face criticism over how they communicate clinical-trial results, the industry's trade association and lobbying group has launched a clinical-trial database for studies conducted by member companies."Recent media coverage of the issue has provided some impetus, but it has been an ongoing project," said Court Rosen, communications manager for the Pharmaceutical Research and Manufacturers of America (PhRMA). Patients and doctors can go to the free database for safety- and efficacy-trial results. When it launches on October 1, it will include studies completed within the past two years on FDA-approved drugs. PhRMA's member board approved the database, but inclusion is still voluntary. "We can't require companies to [disclose results]," Rosen said.